rc – Übersetzung – Keybot-Wörterbuch

Spacer TTN Translation Network TTN TTN Login Français English Spacer Help
Ausgangssprachen Zielsprachen
Keybot 14 Ergebnisse  ar2006.emcdda.europa.eu
  Referanslar  
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), ss. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), pp. 196–8.
Van den Brink, W. (2005), «Epidemiology of cocaine and crack: implications for drug policy and treatment», Sucht 51(4), pp. 196–8.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment“, Sucht 51(4), S. 196-198.
Van den Brink, W. (2005), «Epidemiology of cocaine and crack: implications for drug policy and treatment», Sucht 51(4), pp. 196-198.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), pagg. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), σσ. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), blz. 196-198.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment“, Sucht 51(4), str. 196–198.
Van den Brink, W. (2005): "Epidemiology of cocaine and crack: implications for drug policy and treatment", Sucht 51(4), s. 196–198.
Van den Brink, W. (2005), ”Epidemiology of cocaine and crack: implications for drug policy and treatment”, Sucht vol. 51 (4), s. 196–198.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment”, Sucht 51(4), 196–8. o.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s. 196-8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s 196 –8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), str. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s. 196–8.
  Referanslar  
Roe, E. ve Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), ss. 85–99.
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), pp. 85–99.
Roe, E. et Becker, J (2005), «Drug prevention with vulnerable young people: a review», Drugs: education, prevention and policy, 12(2), pp. 85–99.
Roe, E. und Becker, J. (2005), „Drug prevention with vulnerable young people: a review“, Drugs: education, prevention and policy, 12(2), S. 85-99.
Roe, E. y Becker, J (2005), «Drug prevention with vulnerable young people: a review», Drugs: education, prevention and policy, 12(2), pp. 85-99.
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), pagg. 85–99.
Roe, E. και Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), σσ. 85–99.
Roe, E. en Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), blz. 85-99.
Roe, E. and Becker, J (2005), „Drug prevention with vulnerable young people: a review“, Drugs: education, prevention and policy, 12(2), str. 85–99.
Roe, E. og Becker, J (2005): "Drug prevention with vulnerable young people: a review", Drugs: education, prevention and policy, 12(2), s. 85–99.
Roe, E. ja Becker, J (2005), ”Drug prevention with vulnerable young people: a review”, Drugs: education, prevention and policy, vol. 12 (2), s. 85–99.
Roe, E. és Becker, J (2005), „Drug prevention with vulnerable young people: a review”, Drugs: education, prevention and policy, 12(2), 85–99. o.
Roe, E. og Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85-99.
Roe, E. a Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85 – 99.
Roe, E. in Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), str. 85–99.
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85–99.
  Referanslar  
Farrell, M., Gowing, L., Marsden, J. vd. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, ss. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, pp. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), «Effectiveness of drug dependence treatment in HIV prevention», International journal of drug policy 16S, pp. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), „Effectiveness of drug dependence treatment in HIV prevention“, International journal of drug policy 16S, S. S67-S75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), «Effectiveness of drug dependence treatment in HIV prevention», International journal of drug policy 16S, pp. S67-75.
Farrell, M., Gowing, L., Marsden, J. e altri (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, pagg. S67–75.
Farrell, M., Gowing, L., Marsden, J. κ.ά. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, σσ. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), ‘Effectiveness of drug dependence treatment in HIV prevention’, International journal of drug policy 16S, blz. S67-75.
Farrell, M., Gowing, L., Marsden, J. a kol. (2005), „Effectiveness of drug dependence treatment in HIV prevention“, International journal of drug policy 16S, str. S67–75.
Farrell, M., Gowing, L., Marsden, J. m.fl. (2005): "Effectiveness of drug dependence treatment in HIV prevention", International journal of drug policy 16S, s. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), ”Effectiveness of drug dependence treatment in HIV prevention”, International journal of drug policy vol. 16S, s. 67–75.
Farrell, M., Gowing, L., Marsden, J. és mások (2005), „Effectiveness of drug dependence treatment in HIV prevention”, International journal of drug policy 16S, S67–75. o.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67-75.
Farrell, M., Gowing, L., Marsden, J. a kol. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67 – 75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, str. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67–75.
  Referanslar  
Higgins, S.T., Sigmon, S.C., Wong, C.J. vd. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, ss. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, pp. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), «Community reinforcement therapy for cocaine-dependent outpatients», Archives of general psychiatry 60, pp. 1043–52.
Higgins, S. T., Sigmon, S. C., Wong, C. J. et al. (2003), „Community reinforcement therapy for cocaine-dependent outpatients“, Archives of general psychiatry 60, S. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), «Community reinforcement therapy for cocaine-dependent outpatients», Archives of general psychiatry 60, pp. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. e altri (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, pagg. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. κ.ά. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, σσ. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, blz. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. a kol. (2003), „Community reinforcement therapy for cocaine-dependent outpatients“, Archives of general psychiatry 60, str. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. m.fl. (2003): "Community reinforcement therapy for cocaine-dependent outpatients", Archives of general psychiatry 60, s. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ”Community reinforcement therapy for cocaine-dependent outpatients”, Archives of general psychiatry vol. 60, s. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. és mások (2003), „Community reinforcement therapy for cocaine-dependent outpatients”, Archives of general psychiatry 60, 1043–52. o.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. a kol. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043 – 52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, str. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043–52.
  Referanslar  
Shearer, J. ve Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, ss. 203–11.
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, pp. 203–11.
Shearer, J. et Gowing, L.R. (2004), «Pharmacotherapies for problematic psychostimulant use: a review of current research», Drug and alcohol review 23, pp. 203–11.
Shearer, J. und Gowing, L. R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research“, Drug and alcohol review 23, S. 203-211.
Shearer, J. and Gowing, L.R. (2004), «Pharmacotherapies for problematic psychostimulant use: a review of current research», Drug and alcohol review 23, pp. 203-211.
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, pagg. 203–11.
Shearer, J. και Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, σσ. 203–11.
Shearer, J. en Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, blz. 203-211.
Shearer, J. and Gowing, L.R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research“, Drug and alcohol review 23, str. 203–211.
Shearer, J. og Gowing, L.R. (2004): "Pharmacotherapies for problematic psychostimulant use: a review of current research", Drug and alcohol review 23, s. 203–211.
Shearer, J. ja Gowing, L.R. (2004), ”Pharmacotherapies for problematic psychostimulant use: a review of current research”, Drug and alcohol review vol. 23, s. 203–211.
Shearer, J. és Gowing, L.R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research”, Drug and alcohol review 23, 203–11. o.
Shearer, J. og Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203-11.
Shearer, J. a Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203 – 11.
Shearer, J. in Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, str. 203–11.
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203–11.
  Referanslar  
Bossong, M.G., Van Dijk, J.P. ve Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), ss. 321–3.
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), pp. 321–3.
Bossong, M.G., Van Dijk, J.P. et Niesink, R.J.M. (2005), «Methylone and mCPP, two new drugs of abuse?», Addiction biology 10(4), pp. 321–3.
Bossong, M. G., Van Dijk, J. P. und Niesink, R. J. M. (2005), „Methylone and mCPP, two new drugs of abuse?“, Addiction biology 10(4), S. 321-323.
Bossong, M.G., Van Dijk, J.P. y Niesink, R.J.M. (2005), «Methylone and mCPP, two new drugs of abuse?», Addiction biology 10(4), pp. 321-3.
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), pagg. 321–3.
Bossong, M.G., Van Dijk, J.P. και Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), σσ. 321–3.
Bossong, M.G., Van Dijk, J.P. en Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), blz. 321-323.
Bossong, M.G., Van Dijk, J.P. a Niesink, R.J.M. (2005), „Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), str. 321–323.
Bossong, M.G., Van Dijk, J.P. og Niesink, R.J.M. (2005): "Methylone and mCPP, two new drugs of abuse?", Addiction biology 10(4), s. 321–323.
Bossong, M.G., Van Dijk, J.P. ja Niesink, R.J.M. (2005), ”Methylone and mCPP, two new drugs of abuse?”, Addiction biology vol. 10 (4), s. 321–323.
Bossong, M.G., Van Dijk, J.P. és Niesink, R.J.M. (2005), „Methylone and mCPP, two new drugs of abuse?”, Addiction biology 10(4), 321–3. o.
Bossong, M.G., Van Dijk, J.P. og Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. a Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. in Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), str. 321–3.
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
  Referanslar  
Prinzleve, M., Haasen, C., Zurhold, H. vd. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, ss.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, pp.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), «Cocaine use in Europe – a multi-centre study: patterns of use in different groups», European addiction research 10, pp.147–55.
Poling, J., Oliveto, A., Petry, N. et al. (2006), „Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population“, Archives of general psychiatry 63, S. 219-228.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), «Cocaine use in Europe – a multi-centre study: patterns of use in different groups», European addiction research n.º 10, pp.147-155.
Prinzleve, M., Haasen, C., Zurhold, H. e altri (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, pagg.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. κ.ά. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, σσ.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), ‘Cocaine use in Europe – a multi-centre study: patterns of use in different groups’, European addiction research 10, blz.147-155.
Prinzleve, M., Haasen, C., Zurhold, H. a kol. (2004), „Cocaine use in Europe – a multi-centre study: patterns of use in different groups“, European addiction research 10, str.147–155.
Poling, J., Oliveto, A., Petry, N. m.fl. (2006): "Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population", Archives of general psychiatry 63, s. 219–28.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), ”Cocaine use in Europe – a multi-centre study: patterns of use in different groups”, European addiction research vol. 10, s.147–155.
Prinzleve, M., Haasen, C., Zurhold, H. és mások (2004), „Cocaine use in Europe – a multi-centre study: patterns of use in different groups”, European addiction research 10, 147–55. o.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, s.147-55.
Prinzleve, M., Haasen, C., Zurhold, H. a kol. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, s.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, str.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, s.147–55.
  Referanslar  
Haasen, C., Prinzleve, M., Gossop, M. vd. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users', World psychiatry, 4(3), ss. 173-6.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry 4(3), pp. 173–6.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), «Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users», World psychiatry, 4(3), pp. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), „Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users“, World psychiatry, 4(3), S. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), «Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users», World psychiatry, 4(3), pp. 173-6
Haasen, C., Prinzleve, M., Gossop, M. e altri (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), pagg. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. κ.ά. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), σσ. 173-6.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), ‘Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users’, World psychiatry, “4(3), blz. 173-6”.
Haasen, C., Prinzleve, M., Gossop, M. a kol. (2005), „Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users“, World psychiatry, 4 (3), str. 173–176.
Haasen, C., Prinzleve, M., Gossop, M. m.fl. (2005): "Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users", World psychiatry, oktober.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), ”Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users”, World psychiatry, 4(3), ss. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. és mások (2005), „Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users”, World psychiatry, 4(3), 173-6.o.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, Oktober.
Haasen, C., Prinzleve, M., Gossop, M. a kol. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), s. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users', World psychiatry, 4(3), str. 173-6.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), s. 173-6.
  Referanslar  
Poling, J., Oliveto, A., Petry, N. vd. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, ss.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, pp. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), «Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population», Archives of general psychiatry 63, pp. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), «Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population», Archives of general psychiatry 63, pp. 219-228.
Poling, J., Oliveto, A., Petry, N. e altri (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, pagg. 219–228.
Poling, J., Oliveto, A., Petry, N. κ.ά. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, σσ. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, blz. 219-228.
Poling, J., Oliveto, A., Petry, N. a kol. (2006), „Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population“, Archives of general psychiatry 63“, str. 219–228.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ”Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population”, Archives of general psychiatry vol. 63, s. 219–228.
Poling, J., Oliveto, A., Petry, N. és mások (2006), „Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population”, Archives of general psychiatry 63, 219–28. o.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, s. 219–28.
Poling, J., Oliveto, A., Petry, N. a kol. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, s. 219 – 28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, str. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, s. 219–28.
  Referanslar  
-Y. , O’Brien, M.S. ve Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, ss. 11–22.
Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, pp. 11–22.
Chen, C.-Y., O’Brien, M.S. et Anthony, J.C. (2005), «Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001», Drug and alcohol dependence 79, pp. 11–22.
Chen, C.-Y., O’Brien, M. S. und Anthony, J. C. (2005), „Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001“, Drug and alcohol dependence 79, S. 11-22.
Chen, C.-Y., O’Brien, M.S. y Anthony, J.C. (2005), «Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001», Drug and alcohol dependence 79, pp. 11-22.
Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, pagg. 11–22.
Chen, C.-Y., O’Brien, M.S. και Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, σσ. 11–22.
Chen, C.-Y., O’Brien, M.S. en Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001’, Drug and alcohol dependence 79, blz. 11-22.
Chen, C.-Y., O’Brien, M.S. a Anthony, J.C. (2005), „Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001“, Drug and alcohol dependence 79, str. 11–22.
Chen, C.-Y., O’Brien, M.S. og Anthony, J.C. (2005): "Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001", Drug and alcohol dependence 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. ja Anthony, J.C. (2005), ”Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001”, Drug and alcohol dependence vol. 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. és Anthony, J.C. (2005), „Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001”, Drug and alcohol dependence 79, 11–22. o.
Chen, C.-Y., O’Brien, M.S. og Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001’, Drug and alcohol dependence 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. in Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, str. 11–22.
Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, s. 11–22.
  Referanslar  
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. vd. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, ss.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, pp. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), «A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction», Drug and alcohol dependence 74, pp. 1–13.
Roozen, H. G., Boulogne, J. J., van Tulder, M. W. et al. (2004), „A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction“, Drug and alcohol dependence 74, S. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), «A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction», Drug and alcohol dependence 74, pp. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. e altri (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, pagg. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. κ.ά. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, σσ. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, blz. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. a kol. (2004), „A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,“ Drug and alcohol dependence 74, str. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. m.fl. (2004): "A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction", Drug and alcohol dependence 74, s. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ”A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction”, Drug and alcohol dependence vol. 74, s. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. és mások (2004), „A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction”, Drug and alcohol dependence 74, 1–13. o.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, s. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. a kol. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, s. 1 – 13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, str. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement asroach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, s. 1–13.
  Referanslar  
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. vd. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, ss.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, pp. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), «Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence», American journal of psychiatry 162, pp. 340–9.
Schottenfeld, R. S., Chawarski, M. C., Pakes, J. R. et al. (2005), „Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence“, American journal of psychiatry 162, S. 340-349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), «Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence», American journal of psychiatry 162, pp. 340-349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. e altri (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, pagg. 340–349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. κ.ά. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, σσ. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, blz. 340-349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. a kol. (2005), „Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence“, American journal of psychiatry 162“, str. 340–349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. m.fl. (2005): "Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence", American journal of psychiatry 162, s. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ”Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence”, American journal of psychiatry vol. 162, s. 340–349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. és mások (2005), „Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence”, American journal of psychiatry 162, 340–9. o.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, s. 340-9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. a kol. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, s. 340 – 9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, str. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, s. 340–9.
  Referanslar  
Kandel, D. ve Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use',: Glantz, M. and Pickens, R. (ed) içinde, Vulnerability to Drug Abuse ss.
Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors fro near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse pp. 211–53. American Psychological Association. Washington.
Kandel, D. et Davis, M. (1992), «Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use», in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse pp. 211–53. American Psychological Association. Washington.
Kandel, D. und Davis, M. (1992), „Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use“, in: Glantz, M. und Pickens, R. (Hrsg.), Vulnerability to Drug Abuse, S. 211-253. American Psychological Association. Washington.
Kandel, D. y Davis, M. (1992), «Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use», en: Glantz, M. y Pickens, R. (eds.), Vulnerability to Drug Abuse pp. 211-53, American Psychological Association, Washington.
Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse pagg. 211–53. American Psychological Association. Washington.
Kandel, D. και Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', στο: Glantz, M. και Pickens, R. (επιμ.), Vulnerability to Drug Abuse σσ. 211–53. American Psychological Association. Ουάσιγκτον.
Kandel, D. en Davis, M. (1992), ‘Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use’, in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse, blz. 211-253. American Psychological Association. Washington.
Kandel, D. a Davis, M. (1992), „Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use“, v publikaci: Glantz, M. a Pickens, R. (eds), Vulnerability to Drug Abuse str. 211–253. Americká psychologická asociace. Washington.
Kandel, D. og Davis, M. (1992): "Progression to regular marijuana involvement: Phenomenology and risk factors fro near daily use", i: Glantz, M. og Pickens, R. (red.): Vulnerability to Drug Abuse, s. 211–253. American Psychological Association. Washington.
Kandel, D. ja Davis, M. (1992), ”Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use”, teoksessa: Glantz, M. ja Pickens, R. (toim.), Vulnerability to Drug Abuse, s. 211–253. American Psychological Association, Washington.
Kandel, D. és Davis, M. (1992), „Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use”, in: Glantz, M. és Pickens, R. (szerk.), Vulnerability to Drug Abuse 211–53. o. American Psychological Association. Washington.
Kandel, D. og Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors fro near daily use', in: Glantz, M. og Pickens, R. (redaktører), Vulnerability to Drug Abuse s. 211-53. American Psychological Association. Washington.
Kandel, D. a Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse s. 211 – 53. Americká psychologická asociácia. Washington.
Kandel, D. in Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', v: Glantz, M. in Pickens, R. (eds), Vulnerability to Drug Abuse pp. 211–53. Ameriško psihološko združenje. Washington.
Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse s. 211–53. American Psychological Association. Washington.
  Referanslar  
(2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), ss.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), pp. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), «What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults», Drug and alcohol dependence 68(1), pp. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), „What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults“, Drug and alcohol dependence 68(1), S. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), «What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults», Drug and alcohol dependence 68(1), pp. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. e altri (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), pagg. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. κ.ά. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), σσ. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), blz. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. a kol. (2002), „What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults“, Drug and alcohol dependence 68(1), str. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. m.fl. (2002): "What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults", Drug and alcohol dependence 68(1), s. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ”What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults”, Drug and alcohol dependence vol. 68 (1), s. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. és mások (2002), „What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults”, Drug and alcohol dependence 68(1), 49–64. o.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), s. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. a kol. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), s. 49 – 64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), str. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), s. 49–64.